Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aggrastat
2. Agrastat
3. L 700,462
4. L 700462
5. L-700,462
6. L-700462
7. L700,462
8. Mk 383
9. Mk-383
10. N-(butylsulfonyl)-o-(4-(4-piperidyl)butyl)-l-tyrosine
11. Tirofiban
12. Tirofiban Hydrochloride Monohydrate
1. Tirofiban Hydrochloride Monohydrate
2. 150915-40-5
3. Tirofiban Hcl
4. Tirofiban Hydrochloride Hydrate
5. Aggrastat
6. Tirofiban (hydrochloride Monohydrate)
7. Tirofiban Hcl Hydrate
8. Tirofiban Hcl Monohydrate
9. 142373-60-2
10. Tirofiban Hydrochloride [usan]
11. Mk-383 Hydrochloride
12. Chebi:9606
13. Mk 383
14. Mk-383
15. 6h925f8o5j
16. L-700,462
17. Ncgc00182085-01
18. L 700462
19. Tirofibanhydrochloridemonohydrate
20. Dsstox_cid_28561
21. Dsstox_rid_82833
22. N-(butylsulfonyl)-4-(4-(4-piperidyl)butoxy)-l-phenylalanine Monohydrochloride Monohydrate
23. Dsstox_gsid_48635
24. Tirofiban Hydrochloride (usan)
25. L-700462
26. L-tyrosine, N-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, Monohydrochloride, Monohydrate
27. N-(butylsulfonyl)-o-(4-piperidin-4-ylbutyl)-l-tyrosine Hydrochloride Monohydrate
28. (2s)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic Acid Hydrochloride Monohydrate
29. (s)-2-(butylsulfonamido)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic Acid Hydrochloride Hydrate
30. Cas-150915-40-5
31. Unii-6h925f8o5j
32. Aggrastat (tn)
33. 4-(4-pyridinyl)butanol Hydrochloride
34. Tirofiban, Hydrochloride
35. Schembl41325
36. Chembl3189072
37. Dtxsid5048635
38. Tirofibanhydrochloride Monohydrate
39. Act04424
40. Bcp06919
41. Tox21_112980
42. Mfcd07368623
43. S8594
44. Tox21_112980_1
45. Ccg-222411
46. Cs-0948
47. Tirofiban Hydrochloride [mart.]
48. Tirofiban Hydrochloride [vandf]
49. Ncgc00263584-01
50. (2s)-2-(butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl]propanoic Acid Hydrochloride Hydrate
51. As-11027
52. Bt164476
53. Hy-17369
54. Tirofiban Hydrochloride Monohydrate- Bio-x
55. Tirofiban Hydrochloride [orange Book]
56. D01029
57. Tirofiban Hydrochloride Monohydrate [mi]
58. 373t602
59. A908673
60. Q-101314
61. Tirofiban Hydrochloride Monohydrate [who-dd]
62. Tirofiban Hydrochloride Monohydrate, >=98% (hplc)
63. Q27108448
64. L-tyrosine, N-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, Hydrochloride, Hydrate (1:1:1)
Molecular Weight | 495.1 g/mol |
---|---|
Molecular Formula | C22H39ClN2O6S |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 14 |
Exact Mass | 494.2217358 g/mol |
Monoisotopic Mass | 494.2217358 g/mol |
Topological Polar Surface Area | 114 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 579 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Fibrinolytic Agents
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27293
Submission : 2013-07-03
Status : Active
Type : II
Available Reg Filing : EU |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27293
Submission : 2013-07-03
Status : Active
Type : II
Tirofiban Hydrochloride Monohydrate
About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...
Market Place
ABOUT THIS PAGE
A Tirofiban Hydrochloride Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tirofiban Hydrochloride Monohydrate, including repackagers and relabelers. The FDA regulates Tirofiban Hydrochloride Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tirofiban Hydrochloride Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tirofiban Hydrochloride Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tirofiban Hydrochloride Monohydrate supplier is an individual or a company that provides Tirofiban Hydrochloride Monohydrate active pharmaceutical ingredient (API) or Tirofiban Hydrochloride Monohydrate finished formulations upon request. The Tirofiban Hydrochloride Monohydrate suppliers may include Tirofiban Hydrochloride Monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Tirofiban Hydrochloride Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tirofiban Hydrochloride Monohydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Tirofiban Hydrochloride Monohydrate active pharmaceutical ingredient (API) in detail. Different forms of Tirofiban Hydrochloride Monohydrate DMFs exist exist since differing nations have different regulations, such as Tirofiban Hydrochloride Monohydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tirofiban Hydrochloride Monohydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Tirofiban Hydrochloride Monohydrate USDMF includes data on Tirofiban Hydrochloride Monohydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tirofiban Hydrochloride Monohydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tirofiban Hydrochloride Monohydrate suppliers with USDMF on PharmaCompass.
Tirofiban Hydrochloride Monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tirofiban Hydrochloride Monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tirofiban Hydrochloride Monohydrate GMP manufacturer or Tirofiban Hydrochloride Monohydrate GMP API supplier for your needs.
A Tirofiban Hydrochloride Monohydrate CoA (Certificate of Analysis) is a formal document that attests to Tirofiban Hydrochloride Monohydrate's compliance with Tirofiban Hydrochloride Monohydrate specifications and serves as a tool for batch-level quality control.
Tirofiban Hydrochloride Monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each Tirofiban Hydrochloride Monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tirofiban Hydrochloride Monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tirofiban Hydrochloride Monohydrate EP), Tirofiban Hydrochloride Monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tirofiban Hydrochloride Monohydrate USP).
LOOKING FOR A SUPPLIER?